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Purpose/Objective: At our hospital, a relevant fraction of 
post-prostatectomy patients (pts) are treated with intensity-
modulated whole pelvis radiotherapy (WPRT), leading to the 
irradiation of an extended area of the intestinal cavity. 
Bowel loops (BL) need to be contoured and the dose volume 
histograms (DVH) are evaluated for possible gastrointestinal 
effects. The aim of this study is to evaluate the inter-
observer variability of the bowel volumes obtained by manual 
contouring, which is still the most used method for this 
structure. 
Materials and Methods: Six experienced observers (1 
clinician, 1 radiotherapy technologist, 4 medical physicists) 
delineated BL contours for three pts enrolled in a 
multicentric prospectic observational project. The bowel 
lumen was contoured starting from the most cranial slice 
where lymph-node planning target volume (PTV) was present. 
It continued through sigmoid flexure until the rectum 
contour. Contouring tools included in Eclipse treatment 
planning system (TPS) were used to manually delineate BL. 
Contouring differences were quantified in terms of relative 
volume difference (RD%) and DICE index, that describes the 
agreement between two delineated contours. Differences 
between operators were tested with Wilcoxon test. 
Results: Mean (± standard deviation, SD) volumes of BL were: 
(482 ± 54)cc, (681 ± 50)cc (1278 ± 67)cc for pts A-B-C 
respectively (fig.1). From the point of view of volume 
variations, BL of the pt A resulted the most difficult to be 
contoured (11.2%). RD% with respect to average volume 
values were 17, 2, -11, 3,-14, 4 for each observer 
respectively. For pt B, RD% were -11, -3, 9, 5, -4 ,4; RD%=(6, 
-2, 6, -7, -1, -2) for pt C. In summary, observer 5 
systematically underestimated the BL volumes with 
differences of 6.4% on average. This effect is probably due to 
the contouring habit of observer 5 of being strictly adherent 
to the bowel lumen and some loops can be missed. 
Concerning DICE analysis, average DICE values per pairs of 
observers were assessed. The best agreement was found 
between observer 1 and 5 (0,86±0.12 ,1SD), while the worst 
value for observer 4 and 6 (0.73 ±0.04, 1SD). Average DICE 
for all pair observers were 0.77±0.08, 0.75 ± 0.04 and 
0.83±0.04 for pts A, B, C respectively. Differences between 
pts A-C (p=0.0067) and B-C (p=0,0001) resulted statistically 
significant. 
 
 
Conclusions: Overall inter-observers variations indicated a 
moderately good agreement in the contouring participants as 
resulted by DICE values (average values between 0.75 and 
0.83).  
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Purpose/Objective: Tumor hypoxia is a factor of resistance 
of cells to radiation. Knowing the location of these hypoxic 
zones may allow them to act on selectively modifying the 
standard treatment guidelines. We describe the method used 
to determining the hypoxic tumor volume from the point of 
view of radiotherapy technicians, by planner with rigid 
fusion, as well as the limitations that we have found. 
Materials and Methods: The process is: 
• We make a full body 18F-FDG PET-CT scan in which 
radiopaque markers are placed on the skin of the patient, 
after, this reference points are tattooed. 
• Later we perform 18F-FMISO CT scan and place radiopaque 
markers on tattoos. 
• 4 sets of images are incorporated into Eclipse planner. 
• We fuse the 2 CT scans (18F-FDG and 18F-FMISO). 
• We determine the areas with 18F-FDG uptake 
quantitatively (40% maximum SUV) or by semi quantitative 
algorithm (Source to background) and create FDG uptake 
volume. 
• We determine the areas with 18F-FMISO uptake (ratio 
tumor / mediastinum) and create FMSIO uptake volume. 
• Radiotherapy technician ends the process delimiting organs 
at risk on 18F-FDG CT scan because is the one used to make 
the treatment planning. 
• The radiation oncologist reviewed and suitable volumes and 
creates the FDG GTV , the FDG PTV, the FMSIO GTV and the 
FMISO PTV. 
Results: Currently the method is easy and fast to run by 
technicians (approximately 1 hour and 30 minutes), but the 
firsts cases have generated to us several problems or 
concerns as: 
• The HYPOXIC areas consists of several very small uptakes 
spread throughout the tumor. 
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• Appear uptakes with a size=1 voxel 
• Minimum hypoxic volume to consider in cubic centimeters. 
• Part of the FMISO uptake is outside FDG uptake. 
• We can't visualize 3 series of fused images at once (FDG CT 
– FDG PET – FMISO PET). 
• Placing the patient in the PET-CT unit has to make it 
radiotherapy technician so that involves travel to other 
centers on the PET-CT days. 
• We can't use devices to immobilize the patient because the 
diameter of the PET-CT unit is smaller than Radiotherapy CT. 
Conclusions: 
1. Imaging fusion by existing treatment planning stations is 
simple and does not require excessive time, but specific 
training for radiotherapy technicians is necessary. 
2. 18F-FMISO PET is only authorized within the clinical trials, 
so having few cases, both learning and solving doubts is a 
slow process. 
3. Making a CT in our service can provide a better position by 
using immobilization devices by an expert radiotherapy 
technician, but that would cause more radiation to the 
patient. 
 
 
Electronic Poster: RTT track: Treatment planning and dose 
calculation  
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Purpose/Objective: To assess if DIBH achieved dose sparing 
for organs-at-risk in left breast radiotherapy. These patients 
have an increased risk of cardiac complications post-
treatment compared to right breast patients. Deep 
inspiration breath-hold (DIBH) could potentially reduce dose 
to organs-at-risk without compromising target dose, thus 
potentially reducing complication incidence and improving 
overall patient survival. 
Materials and Methods: Free breathing (FB) and DIBH CT 
planning scans obtained using Varian RPM Gating software for 
28 left breast/left chest wall (plus/minus supraclavicular 
field) patients treated between January 2008-December 2013 
were retrospectively re-contoured and re-planned. Organs-
at-risk included the combined lungs, left lung, heart and left 
anterior descending coronary artery (LADCA). Field-in-field 
tangential technique (mono-isocentric for supraclavicular 
patients) and Anisotropic Analytical Algorithm (AAA) were 
used for dose calculations. Maximum plan doses were kept 
within 1% agreement between FB and DIBH plans for 
comparative purposes. Quantitative analysis of plan dose 
differences was then carried out. 
Results: Lung dose was not affected by DIBH. Heart Dmax was 
reduced by 34.5% (FB=41.81Gy, SD=3.963Gy vs DIBH=27.39Gy, 
SD=12.393Gy, p<0.000). Heart Dmean was reduced by 32.6% 
(FB=1.817Gy, SD=0.627Gy vs DIBH=1.224Gy, SD=0.344Gy, 
p<0.000). DIBH removed heart in 28.6% (n=8) of participants’ 
treatment fields. LADCA Dmax was reduced by 47.8% (DIBH 
mean=15.56Gy, SD=10.62Gy vs. FB mean=29.82Gy, 
SD=10.05Gy, p<0.000), and LADCA Dmean by 52% (DIBH 
mean=5.23Gy, SD=1.94Gy vs. FB mean=10.88Gy, SD=3.95Gy 
p<0.000). Amplitude depths were not correlated with dose 
reductions. 
Conclusions: DIBH results in heart and LADCA dose 
reductions, without increasing lung dose. Further long-term 
follow-up is required to evaluate the clinical implications for 
patients.  
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Purpose/Objective: To compare the dosimetric difference of 
volumetric modulated arc therapy(VMAT) and fixed-jaw 
technique in volumetric modulated arc therapy(FJT-VMAT) 
for nasopharyngeal carcinoma(NPC). 
Materials and Methods: VMAT and FJT-VMAT plans were 
designed to 15 nasopharyngeal carcinoma patients by 
planning treatment system(Eclipse 10.0),respectively. The 
target and risk organ doses, conformity indexes (CI), 
homogeneity indexes (HI), low dose volume of normal tissue, 
monitor units(MU) and treatment time (TT) were compared 
between the two kinds of plans. 
Results: Two Plans could meet the clinical objectives. The 
Dmean, D50, D2 of PGTVnd, PTV1, PTV2 were lower in FJT-VMAT 
plans than in VMAT plans (P<0.05). There were no significant 
different in PGTVnx between them. FJT-VMAT plans had 
lower PRVBstem(Dmax, V54), PRVsc(Dmax), Parotid(Dmean, V30) and 
B-P( V20, V30)(P<0.05), but no significantly different with 
other OARs as compared with VMAT plans. FJT-VMAT 
plans(683±87)increased the monitor units(MU) by 22%(t =-
5.78, P =0.000), as compared with VMAT plans(559±62). The 
treatment time of two plans were consistent (about 2 min).  
Conclusions: FJT-VMAT plans as compared with VMAT plans, 
showing better target coverage, part of OARS and B-P 
sparing, which MU was slightly increased but not significantly 
different between the two plans of treatment time. 
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Purpose/Objective: To achieve homogeneous dose 
distribution in the intensity-modulated radiotherapy (IMRT) 
for Stage III lung cancer is challenging. A novel method 
utilizing base dose function (BDF) was proposed to overcome 
the difficulty and was evaluated in this study. 
Materials and Methods: CT scan data of 13 patients were 
enrolled. Three optimizing approaches were applied to obtain 
clinically acceptable plans: 1) Conventional optimizing (CO) 
